Clinical management of patients with <i>ASXL1</i> mutations and Bohring–Opitz syndrome, emphasizing the need for Wilms tumor surveillanceBianca Russell, John M. Graham, Leslie G. Biesecker et al.|American Journal of Medical Genetics Part A|2015Cited by 66